- Home
- J&J Innovative Medicine
J&J Innovative Medicine
Harnessing the human genome is the future of healthcare—and Johnson & Johnson is helping lead the way
The company’s partnership with the largest human genome sequencing project in the world will increase scientists’ understanding of genetic diseases and help create new interventions. Here, a look at the breakthroughs that have guided the understanding of the power of DNA.
What it’s like when your baby has a rare blood disorder
A condition called fetal and neonatal alloimmune thrombocytopenia (FNAIT) can be deadly in newborns. That’s why Johnson & Johnson is passionate about developing a treatment for the disorder.
What you need to know about Johnson & Johnson’s 2023 third-quarter earnings
Check out this infographic breakdown of the company’s third-quarter 2023 performance, with key highlights from its Innovative Medicine and MedTech businesses.
Behind the relentless pursuit of multiple myeloma cures
Johnson & Johnson has been dedicated to developing innovative treatments for blood cancers for nearly 20 years. Scientist Kodandaram “Ram” Pillarisetti is at the forefront of the company’s commitment to working toward its goal of one day eliminating the disease.
What you need to know about Johnson & Johnson’s 2023 second-quarter earnings
Check out this infographic breakdown of the company’s second-quarter 2023 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
5 things we now know about myasthenia gravis
Discover more about the disease, learn how one woman lives with this rare autoantibody condition and why Johnson & Johnson is working to find new treatments for patients like her.
What you need to know about Johnson & Johnson’s 2023 first-quarter earnings
Check out this infographic breakdown of the company’s first-quarter 2023 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
Johnson & Johnson named to Fortune‘s 2023 America’s Most Innovative Companies list
The company has been recognized on the inaugural list for its innovative spirit—a trait that’s been at the heart of Johnson & Johnson’s mission to improve health for people across the globe for over a century.
What is a rare disease?
It’s estimated that over 300 million people around the globe are living with a rare disease. For Rare Disease Day, here’s what to know.
Microbiome researcher Jeffrey Gordon receives the 2022 Dr. Paul Janssen Award for biomedical research
Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health. The winner for 2022 is internationally known for his research on the human gut microbiome and its impact on health and disease.